Annual EBITDA
$158.83M$4.32M-2.65%
Summary
- Current Value
- As of today, GDRX annual EBITDA is $158.83M, down -2.65% on
- Historical Performance
- GDRX annual EBITDA is up +143.06% over the past 3 years, and up +0.80% over the past 5 years
- All-Time High Comparison
- GDRX annual EBITDA is currently -2.65% below its historical high of $163.15M set on
- 3-Year Low Comparison
- GDRX annual EBITDA is +67.74% above its 3-year low of $94.69M reached on an earlier date
- Sector Comparison
- GDRX annual EBITDA is higher than 87.63% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $158.83M | -2.6% | +143.1% | +0.8% | +467.1% | |
| Quarterly EBITDA | $47.85M | +25.9% | +169.6% | +190.6% | +53.5% | |
| TTM EBITDA | $191.12M | +35.4% | +102.4% | +129.8% | +513.0% | |
| Price | $2.85 | -35.4% | -41.1% | -93.2% | – | |
| PE Ratio | 33.18 | -68.0% | – | – | – | |
| Annual Revenue | $792.32M | +5.6% | +6.3% | +104.1% | +697.3% | |
| Annual EPS | $0.04 | +293.5% | +166.3% | -62.3% | +306.9% | |
| Annual EBIT | $89.29M | +73.8% | +222.3% | -37.0% | +372.0% | |
| Annual Net Income | $16.39M | +284.8% | +164.9% | -61.4% | +310.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $163.15M | -2.6% | |
| 5Y | $163.15M | -2.6% | |
| All | $163.15M | -2.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $94.69M | N/A | +67.7% |
| 5Y | -$244.48M | N/A | +165.0% |
| All | -$244.48M | +165.0% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $158.83M | -2.6% | |
| $163.15M | +72.3% | |
| $94.69M | +44.9% | |
| $65.35M | +126.7% | |
| -$244.48M | -255.2% |
| Year | Value | Change |
|---|---|---|
| $157.57M | +81.0% | |
| $87.07M | +46.6% | |
| $59.41M | +112.1% | |
| $28.01M | - |
FAQ
What is the current annual EBITDA of GDRX?
As of today, GDRX annual EBITDA is $158.83M
What is 1-year change in GDRX annual EBITDA?
GDRX annual EBITDA is down -2.65% year-over-year
What is 3-year change in GDRX annual EBITDA?
GDRX annual EBITDA is up +143.06% over the past 3 years
How far is GDRX annual EBITDA from its all-time high?
GDRX annual EBITDA is currently -2.65% below its historical high of $163.15M set on December 31, 2023
How does GDRX annual EBITDA rank versus sector peers?
GDRX annual EBITDA is higher than 87.63% of companies in Healthcare sector
When is GDRX next annual earnings release?
The next annual earnings release for GDRX is on
Quarterly EBITDA
$47.85M$414.00K+0.87%
Summary
- Current Value
- As of today, GDRX quarterly EBITDA is $47.85M, up +0.87% on
- Historical Performance
- GDRX quarterly EBITDA is up +25.91% year-over-year, and up +169.64% over the past 3 years
- All-Time High Comparison
- GDRX quarterly EBITDA is currently -4.19% below its historical high of $49.95M set on
- 3-Year Low Comparison
- GDRX quarterly EBITDA is +134.02% above its 3-year low of $20.45M reached on
- Sector Comparison
- GDRX quarterly EBITDA is higher than 85.56% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $47.85M | +0.9% | +25.9% | +169.6% | +190.6% | |
| Annual EBITDA | $158.83M | – | -2.6% | +143.1% | +0.8% | |
| TTM EBITDA | $191.12M | +5.4% | +35.4% | +102.4% | +129.8% | |
| Price | $2.85 | -35.1% | -35.4% | -41.1% | -93.2% | |
| PE Ratio | 33.18 | -35.1% | -68.0% | – | – | |
| Quarterly Revenue | $196.03M | -3.5% | +0.4% | +4.7% | +39.6% | |
| Quarterly EPS | $0.00 | -91.1% | -68.6% | +103.2% | +102.5% | |
| Quarterly EBIT | $26.42M | -4.7% | +29.1% | +797.8% | +144.6% | |
| Quarterly Net Income | $1.12M | -91.3% | -71.8% | +102.7% | +102.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $49.95M | -4.2% | |
| 3Y | $49.95M | -4.2% | |
| 5Y | $49.95M | -4.2% | |
| All | $49.95M | -4.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $45.88M | N/A | +4.3% |
| 3Y | $20.45M | +134.0% | |
| 5Y | -$289.39M | N/A | +116.5% |
| All | -$289.39M | +116.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of GDRX?
As of today, GDRX quarterly EBITDA is $47.85M
What is GDRX quarterly EBITDA most recent change?
GDRX quarterly EBITDA was up +0.87% on September 30, 2025
What is 1-year change in GDRX quarterly EBITDA?
GDRX quarterly EBITDA is up +25.91% year-over-year
How far is GDRX quarterly EBITDA from its all-time high?
GDRX quarterly EBITDA is currently -4.19% below its historical high of $49.95M set on March 31, 2025
How does GDRX quarterly EBITDA rank versus sector peers?
GDRX quarterly EBITDA is higher than 85.56% of companies in Healthcare sector
When is GDRX next earnings release?
The next earnings release for GDRX is on
TTM EBITDA
$191.12M$9.85M+5.43%
Summary
- Current Value
- As of today, GDRX TTM EBITDA is $191.12M, up +5.43% on
- Historical Performance
- GDRX TTM EBITDA is up +35.35% year-over-year, and up +102.44% over the past 3 years
- All-Time High Comparison
- GDRX TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GDRX TTM EBITDA is +138.81% above its 3-year low of $80.03M reached on
- Sector Comparison
- GDRX TTM EBITDA is higher than 86.28% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $191.12M | +5.4% | +35.4% | +102.4% | +129.8% | |
| Annual EBITDA | $158.83M | – | -2.6% | +143.1% | +0.8% | |
| Quarterly EBITDA | $47.85M | +0.9% | +25.9% | +169.6% | +190.6% | |
| Price | $2.85 | -35.1% | -35.4% | -41.1% | -93.2% | |
| PE Ratio | 33.18 | -35.1% | -68.0% | – | – | |
| TTM Revenue | $800.65M | +0.1% | +1.3% | +0.6% | +56.9% | |
| TTM EPS | $0.09 | -7.5% | +319.1% | +149.0% | +62.4% | |
| TTM EBIT | $109.95M | +5.7% | +138.7% | +162.4% | +72.5% | |
| TTM Net Income | $31.75M | -8.2% | +295.8% | +144.9% | +59.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $191.12M | at high | |
| 3Y | $191.12M | at high | |
| 5Y | $191.12M | at high | |
| All | $191.12M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $157.84M | N/A | +21.1% |
| 3Y | $80.03M | +138.8% | |
| 5Y | -$325.99M | +158.6% | |
| All | -$325.99M | +158.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of GDRX?
As of today, GDRX TTM EBITDA is $191.12M
What is GDRX TTM EBITDA most recent change?
GDRX TTM EBITDA was up +5.43% on September 30, 2025
What is 1-year change in GDRX TTM EBITDA?
GDRX TTM EBITDA is up +35.35% year-over-year
How far is GDRX TTM EBITDA from its all-time high?
GDRX TTM EBITDA is currently at its all-time high
How does GDRX TTM EBITDA rank versus sector peers?
GDRX TTM EBITDA is higher than 86.28% of companies in Healthcare sector
When is GDRX next earnings release?
The next earnings release for GDRX is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- GDRX Official Website www.goodrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1809519/000180951925000143/0001809519-25-000143-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1809519/000180951925000040/0001809519-25-000040-index.htm
- GDRX Profile on Yahoo Finance finance.yahoo.com/quote/GDRX
- GDRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gdrx